Thursday, Zimmer Biomet Holdings Inc (NYSE:ZBH) reported fourth-quarter 2023 net sales of $1.94 billion, up 6.3% Y/Y (+6.1% on a constant currency basis), almost in line with the consensus of $1.93 billion.
Net earnings for the fourth quarter were $419.2 million, or $458.1 million on an adjusted basis. Adjusted EPS reached $2.20, beating the consensus of $2.15.
The company initiated a global restructuring program in late 2023 to optimize its cost base and …
Leave a Reply